CRP and type 2 diabetes mellitus: Furthermore, several studies have shown the capacity of statins to reduce CRP levels in patients with acute coronary disease and type II diabetes, despite lack of changes in cholesterol levels (Kluft et al., 1999; Strandberg et al., 1999).